See the cash flow statements. Why did cash flow from operations increase from Rs 53.79 crore to Rs 212.09 crore for Glaxo? Did all the firms experience an increase in cash flow from operations? If not, why not? Is the cash flow from operations more or less than the cash flow from investing activities for these firms? If yes, why? If not, why not? For DRL the cash flow from operations in 2000 was Rs 86.63 crore whereas the cash flow from investing was Rs 110.18 crore.

Where did DRL get the additional cash to finance the investment? Can this situation continue indefinitely?